Mechanisms of resistance to CAR T cell therapies

Chimeric antigen receptor (CAR)-engineered T cells have demonstrated remarkable success in the treatment of B cell malignancies. FDA approval of these therapies represents a watershed moment in the development of therapies for cancer. Despite the successes of the last decade, many patients will unfo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Semin Cancer Biol
Asıl Yazarlar: Singh, Nathan, Orlando, Elena, Xu, Jun, Xu, Jie, Binder, Zev, Collins, McKensie A., O’Rourke, Donald M., Melenhorst, J. Joseph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7684646/
https://ncbi.nlm.nih.gov/pubmed/31866478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2019.12.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller